Arcis Biotechnology provide nucleic acid sample preparation solutions. They have made the process of obtaining genetic material from biological samples less time consuming so it can be done in less than 3 minutes.
days to go:
Expired
investment:
£1,146,318
Belluscura aims at attending millions of people worldwide who are suffering from chronic lung diseases by providing them with the X-PLOR, portable, a lightweight, oxygen delivery device. It has developed it mainly to improve both the mobility and the life quality of the patients suffering from Chronic Obstructive Pulmonary Disease globally. It also has an exclusive license to a patented portable oxygen concentrator, the X-PLOR, that supplies 96% pure oxygen to patients 24/7. It's X-PLOR weights only 1.4kg and is 33% lighter, and provides 37% more oxygen per kg than its leading opponents. As smoke, pollution, and lives increase, the oxygen market will continue to grow from £1.1bn to £1.9bn by 2024. So, according to its market research, a 3% market share within 3 years could generate £46m in sales. With the funds raised, it is planning to extend its proprietary oxygen platform technology into other multi £bn markets such as wound care and sleep. Furthermore, it has filed patents on a next-generation portable artificial lung.
days to go:
Expired
investment:
£543,670
BiVictriX Therapeutics is a pharmaceutical company that are developing ADC's (Antibody Drug Conjugates) in the field of Oncology. They have invented a strategy that improves ADC selectivity towards cancer cells.
days to go:
Expired
investment:
£451,506
The British Journal of Photography (BJP) is a monthly magazine dedicated to comtemporary photography. In the last 3 years, the print magazine has been completely re-designed and since then, BJP have launched new apps, new events and awards aimed at capturing the next generation of readers.
days to go:
Expired
investment:
£399,720
Buildy is an online platform that aims at making construction hiring easy by eliminating the expensive middlemen, thereby, saving time and money for both employers and employees. The platform was shortlisted as the Best Recruitment Innovation at Building Innovation Awards. Buildy has already signed up around 100 tradespeople and 46 employers. The company will streamline the hiring process through automation of job by bidding for jobs, matching algorithms, ratings, online chat, reviews, and providing the skilled workers and tradespeople more control via a better user interface. With the proceeds, the company will seek to fast track the Buildy app and help the company become the top recognised brand in construction staff hiring.
days to go:
Expired
investment:
£17,380
Carnot is developing hydrogen engines with key components manufactured from ceramics able to withstand fuel combustion temperatures, eliminating the need for cooling systems and doubling the efficiencies of modern engines. The company argues that modern engines waste on average one-third of fuel energy to cool systems that stop metallic components from melting. Carnot claims that its engines eliminate this waste doubling efficiency, halve fuel costs and CO2 and achieve net-zero operation by operating on biofuels and hydrogen benefiting the long haul transport, marine and primary off-grid power markets. Carnot has raised over £600,000 including a pre-seed round in 2020 for £357,000 at a pre-money valuation of £2 million, a £300,000 Innovate UK grant and another £300,000 Eureka Eurostar’s grant. Carnot has a 5-year, 3-phase exit strategy and will begin licensing its IP at the end of 2023 at which point it will begin generating revenue. It will eventually look for acquisition from one of its manufacturing partners in 2025 after demonstrating industry acceptance of its technology.
days to go:
Expired
investment:
£262,500
Cellmed is an immuno-oncology company that are developing treatments for ovarian cancer. Their lead product PROCURE a dendritic cell vaccine and they are now looking to expand the treatment to target solid tumors.
days to go:
Expired
investment:
£520,294
CFP is a family owned business which is backed by British Business Bank. The company has created the world’s leading carbon fibre composite recycling operation. CFP has drawn a pipeline of business across a range of applications and is now involved with 25+ businesses across automotive, defence, and oil and gas industries. The company has taken concrete steps to improve its sales team to reflect its end market focus. CFP believes that as the adoption of the products occurs, the markets are adequately plentiful and different for CFP to achieve its aspirations and that the exit valuation fixed out in the Investment Memorandum remains achievable.
days to go:
Expired
investment:
Withheld
Carbon Negative Permeable Pavement Systems (CNPPS) offers Carbon Negative solution for hard surfaces like pavements and road networks. The company uses secondary aggregates, waste products and carbon-negative materials in its pavement systems which absorb more carbon in the manufacturing process than the carbon emitted per square meter by traditional carbon-intensive road construction methods. CNPPS's products are also permeable and can reduce flooding caused by rainwater run-off, thereby improving road safety. The company argues that its products are an estimated 5-8% less expensive than the currently used processes, having the potential to lessen the infrastructure budgets of the UK government. CNPPS requires initial funding to carry out a trial of its system by the Highways of England. The company will use the investment funds to trial, accredit, CE mark and market CNPPS, and generate buyer interest in its products.
days to go:
Expired
investment:
Withheld
Combat Medical have created an innovative method to treat bladder cancer by using heated chemotherapy. By heating the treatment the membrane is more permeable and is able to penetrate further.
days to go:
Expired
investment:
£1,725,220
